Thirty-seven-year-old Ed Hunt has become the first person to receive an experimental vaccine designed to protect against the Bundibugyo species of Ebola. Developed by scientists in Oxford using technology from the Covid-19 vaccine, the trial aims to establish safety and immune response - a key step in preventing future outbreaks of this deadly virus.